Memantine Sandoz (Memantine Hydrochloride)

Memantine works by blocking the NMDA‑type glutamate receptors in a non‑competitive manner. This reduces excessive calcium entry into neurons, limiting excitotoxic damage and supporting neuronal health, which can slow the progression of cognitive decline.

The specific dose and titration schedule for Memantine Sandoz are determined by the prescribing clinician based on the patient’s condition, age, renal function, and other factors. The prescriber will set the appropriate regimen.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Memantine Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, whereas other approved agents such as donepezil, rivastigmine and galantamine are acetylcholinesterase inhibitors. Memantine is typically used in moderate to severe disease and may be combined with an acetylcholinesterase inhibitor for broader symptomatic coverage.

Memantine Sandoz tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep the product away from moisture, heat and direct sunlight to maintain stability.

Memantine Sandoz is taken orally, usually once daily after a gradual dose‑escalation period as directed by the prescriber. The tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious adverse events, though uncommon, include seizures, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, hepatic injury, cardiac arrhythmias, and emergence of suicidal thoughts. Patients should be monitored closely for any of these signs.

Memantine Sandoz is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is advised in individuals with uncontrolled seizures, severe renal impairment, or those taking other NMDA antagonists.